New hope for Tough-to-Treat breast cancer: testing powerful drug combos

NCT ID NCT03742102

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing several new combinations of cancer drugs for women with advanced triple-negative breast cancer that has spread. The main goal is to see if these combinations can effectively control the cancer and are safe for patients who have not yet received treatment for their metastatic disease. Researchers will test different drug pairings, including an immunotherapy drug called durvalumab, to find the most promising options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Tucson, Arizona, 85715, United States
Research Site

Columbia, Maryland, 21044, United States
Research Site

Boston, Massachusetts, 02114, United States
Research Site

Boston, Massachusetts, 02215, United States
Research Site

Grand Rapids, Michigan, 49503, United States
Research Site

St Louis, Missouri, 63110, United States
Research Site

Dallas, Texas, 75246, United States
Research Site

Williamsburg, Virginia, 23188, United States
Research Site

Kelowna, British Columbia, V1Y 5L3, Canada
Research Site

London, Ontario, N6A 4L6, Canada
Research Site

Greenfield Park, Quebec, J4V 2H1, Canada
Research Site

Montreal, Quebec, H4A 3J1, Canada
Research Site

Gdansk, 80-952, Poland
Research Site

Krakow, 31-501, Poland
Research Site

Lublin, 20-090, Poland
Research Site

Opole, 45-060, Poland
Research Site

Rzeszów, 35-021, Poland
Research Site

Warsaw, 02-781, Poland
Research Site

Warsaw, 04-141, Poland
Research Site

Seoul, 03080, South Korea
Research Site

Seoul, 05505, South Korea
Research Site

Seoul, 06351, South Korea
Research Site

Kaohsiung City, 80756, Taiwan
Research Site

Taichung, 40447, Taiwan
Research Site

Tainan, 70403, Taiwan
Research Site

Taipei, 10002, Taiwan
Research Site

Taipei, 112, Taiwan
Research Site

Taoyuan District, 333, Taiwan
Research Site

Cambridge, CB2 0QQ, United Kingdom
Research Site

London, EC1M 6BQ, United Kingdom
Research Site

Manchester, M20 4BX, United Kingdom
Research Site

Oxford, OX3 7LE, United Kingdom

Conditions

Explore the condition pages connected to this study.

TRIPLE NEGATIVE BREAST NEOPLASMS